Bing

SEARCH HISTORY

Meanwhile, the company’s stock has dropped by more than 13% since the beginning of the year, although in the latest financial results, for the first quarter of 2015, Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) …
INSIDER MONKEY · 1 day ago
Vanda Pharmaceuticals Inc
Vanda Pharmaceuticals Inc. (VNDA) announced after the bell Tuesday that the European Commission has approved HETLIOZ, for the treatment of Non-24-Hour Sleep-Wake Disorder in completely blind adults in the European Union. The stock is now up 0.
Realtime Business News · 1 hour ago
Vanda Pharmaceuticals
Trade-Ideas LLC identified Vanda Pharmaceuticals ( VNDA) as a strong on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Vanda Pharmaceuticals as such a stock due to the following factors: VNDA has an ...
The Street · 6/24/2015
More from Bing News
During the June 3 trading session, VNDA shares vaulted 12.06 percent to $11.43. Trading volume was exceptionally heavy, with more than 3.65 million shares changing hands, compared with the stock’s average daily trading volume of approximately 797 …
Wall Street Sector Selector · 6/25/2015
Vanda Pharmaceuticals's stock is up 6.9% to $13.79 on heavy trading volume ... Vanda Pharmaceuticals (NASDAQ:VNDA) has potential upside of 29.1% based on a current price of $13.79 and analysts' consensus price target of $17.80. Vanda …
Financial News Network Online · ByRobert Cotter · 6/24/2015
Vanda Pharmaceuticals
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) gained more than 8 percent in after-hours trading ... gained 2.7 percent to $699.77 in post-market trading after the company announced a 7-for-1 stock split. FibroGen Inc (NASDAQ: FGEN) rose 2 percent in …
Benzinga · 6/24/2015
Vanda Pharma
Netflix plans for a 7-for-1 stock split. Tollbooth Index edged down 9.86 to ... Vanda Pharmaceuticals Inc (VNDA) gained 5% or 64 cents to $13.54 after the biopharmaceutical company presented positive results from a schizophrenia relapse prevention study ...
ticker.com · 6/24/2015
Vanda Pharmaceuticals, Inc. (VNDA) was a big mover last session with its shares rising just over 12% on the day. The upside was owing to the announcement that Mihael H. Polymeropoulos, M.D., Vanda's President and CEO, will deliver a corporate …
Yahoo Finance · 6/3/2015
Vanda Pharmaceuticals, Inc. (VNDA - Snapshot Report) was a big mover last session with its shares rising just over 12% on the day. The upside was owing to the announcement that Mihael H. Polymeropoulos, M.D., Vanda's President and CEO, will deliver …
ZACKS · 6/3/2015
Nektar Therapeutics (NASDAQ: NKTR) 5.8% HIGHER; will replace Caseys General Stores in the S&P SmallCap 600 Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) 4.6% HIGHER ... of Directors has approved a …
StreetInsider · 6/23/2015